Atlas Trials

Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease

Clinical trial NCT05599347 · RECRUITING

Trial details

NCT number
NCT05599347
Sponsor
Rambam Health Care Campus
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease RelapseBiological Substance; Adverse Effect
Start date
2023-04-24
Primary completion
2026-09-10
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.